The Tata Sons board, meeting in Mumbai on 17 September 2026, reappointed N. Chandrasekaran as Executive Chairman for five years, taking his tenure to February 2032.
The vote was 4-1; Tata Trusts Chairman Noel Tata voted against it.
Tata Trusts, which owns about 66% of Tata Sons, called the resolution a 'legal nullity' under the company's Articles of Association.
In August, Chandrasekaran had said he would not seek another term. The board's Nomination and Remuneration Committee asked him on 3 September to reconsider.
The dispute comes as the RBI has rejected Tata Sons' request to surrender its NBFC registration, which revives the listing requirement for upper-layer NBFCs.
Chandrasekaran takes over as Tata Sons Chairman after Cyrus Mistry's removal and Ratan Tata's interim stint
Reappointed for a second five-year term (to February 2027)
Noel Tata becomes Chairman of Tata Trusts after Ratan Tata's death
Chandrasekaran tells the board he will not seek reappointment
Nomination and Remuneration Committee asks him to reconsider
RBI rejects Tata Sons' request to give up its NBFC registration
Board reappoints him 4-1; Tata Trusts calls it a legal nullity
Principal holding company and promoter of the Tata Group
Group of philanthropic trusts; majority shareholder (about 66%) of Tata Sons
Regulates NBFCs, including core investment companies such as Tata Sons
A company's internal rulebook. Tata Trusts says the resolution breached the provisions governing its nominee directors, so it is void.
Gives the RBI its power to register and regulate NBFCs. Tata Sons is registered as an NBFC under it.
Creates base, middle, upper and top layers of NBFCs; an NBFC placed in the upper layer must list within three years
Banking Awareness > NBFC regulation; Current Affairs > Appointments
GS Paper III > Indian Economy > Corporate governance and financial regulation
A company's internal rules on management, directors' powers and shareholder rights
An NBFC that holds at least 90% of its net assets as investments in group companies
An NBFC the RBI identifies as systemically significant under Scale-Based Regulation; it faces stricter norms, including mandatory listing